Pharma News
-
First-of-its-kind osteoarthritis study done in India
Pharma | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2012
Bangalore: Signaling relief to over 15 million knee-osteoarthritis patients in India, the world's first study "Osteoart...Read more
-
Novartis liver cancer trial with Afinitor flops
Pharma | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013
Singapore: Novartis highlighted that the results of a global phase III study showed that Afinitor (everolimus) did not e...Read more
-
Oramed submits pre-IND for exenatide to FDA
Pharma | Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, submitted a pre-Investigational New Drug (...Read more
-
Alexion to acquire Synageva biopharma for $8.4 bn deal
Pharma | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2015
Singapore: Alexion pharmaceuticals recently announced the acquisition of Synageva Biopharma for $8.4 billion. US-based S...Read more
-
Director resigns at China Nepstar Chain Drugstore
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Mr. Gary Siu Kwan Sik has resigned as an independent director of China Nepstar Chain Drugstore, the largest d...Read more
-
Pharma | News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2012
Singapore: DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in A...Read more
-
Innovative dual chamber syringe for pharma market
Pharma | News | By BioSpectrum Bureau | 0 Comment | 05 Jun, 2012
Singapore: Japan-based Arte and German company ProJect Pharmaceutics are working closely on the development of a new typ...Read more
-
Indian FIPB clears pharma FDI proposals worth $536 mn
Pharma | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
New Delhi: The Indian Foreign Investment Promotion Board (FIPB), which is the foreign investment approval authority, has...Read more
-
Arvind sets up $42.37 mn plant top tap US market
Pharma | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: Indian pharmaceutical firm, Arvind Remedies has been gearing up to take the US market by storm. The company h...Read more
-
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Agnitio, a leader in healthcare sector closed-loop marketing technology, continues to expand its global pres...Read more
-
Takeda to acquire LigoCyte Pharma
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Takeda Pharmaceutical Company and LigoCyte Pharmaceuticals, jointly announced that Takeda's wholly-owned sub...Read more
-
Ranbaxy, Gilead sign licensing agreement
Pharma | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2012
New Delhi: Ranbaxy Laboratories has entered into an in-licensing agreement with Gilead Sciences to promote access to hig...Read more
-
Universities get $15mn from Teva for CNS R&D
Pharma | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Israel-based Teva is undergoing re-organization in order to mitigate lost revenue from increased competition ...Read more
-
NSF brings Secondary Reference Standards to India
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: NSF International, an independent global public health and safety organization which develops standards, and ...Read more
-
Takeda, Resolve to develop, sell autoimmune drugs
Pharma | News | By BioSpectrum Bureau | 0 Comment | 28 Feb, 2013
Singapore: Takeda Pharmaceutical has entered into a partnership with Resolve Therapeutics to develop compounds for the t...Read more
-
Bayer initiates Phase II/III trial of a new compound for Hemophilia A
Pharma | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore, July 09, 2012: Bayer HealthCare has started to enroll patients in an international Phase II/III trial to eval...Read more
-
GlobalData: Osteoporosis market to be $8 bn
Pharma | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2013
Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the ...Read more
-
Cipla gets drug pricing breather from Delhi Court
Pharma | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: India's Delhi High Court has extended the operation of its earlier order asking the central government not t...Read more
